• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

AVEO Pharmaceuticals

edit

AVEO is a late-stage biopharmaceutical company focused on the discovery and development of targeted cancer therapeutics. AVEO’s proprietary, integrated cancer biology platform enables the company to pursue highly efficient drug development strategies in oncology that increase the probability of clinical success and provides a discovery engine for high-value targets and therapies.

This approach has resulted in a balanced pipeline of novel cancer therapies focused on well-validated targets (VEGFR, EGFR) and promising novel targets (HGF, FGFR, ErbB3 and NOTCH), as well as collaborations with Eli Lilly, Merck, OSI Pharmaceuticals, Schering-Plough and Biogen Idec.

Recent Milestones

edit

• 
  AVEO Pharmaceuticals — Aveo Pharmaceuticals files for $100M stock offering (6/15/11)
  Posted 6/15/11 at 6:07pm via masshightech.com
• 
  AVEO Pharmaceuticals — it will receive an initial $15 million and up to $540 million in milestone payments in an exclusive license agreement with Centocor Ortho Biotech Inc. (5/31/11)
  Posted 5/31/11 at 9:01am via masshightech.com
• 
  AVEO Pharmaceuticals — Aveo nabs $1.4B deal with Astellas for Ph3 cancer drug (2/17/11)
  Posted 2/17/11 at 5:50am via fiercebiotech.com
• 
  AVEO Pharmaceuticals — AVEO and Astellas Pharma Inc., of Tokyo, have formed a development and commercialization deal in which AVEO will bring in $125 million upfront and up to $1.3 billion in potential milestone payments (2/17/11)
  Posted 2/17/11 at 10:27am via masshightech.com
• 
  AVEO Pharmaceuticals — has presented results on a pair of cancer treatments at the Symposium of the European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research in Berlin, Germany. (11/19/10)
  Posted 11/22/10 at 5:09am via masshightech.com
• 
  AVEO Pharmaceuticals — Aveo Pharmaceuticals Inc. is planning a private placement intended to bring in $61 million to the company. (10/29/10)
  Posted 11/2/10 at 9:11am via masshightech.com
• 
  AVEO Pharmaceuticals — AVEO Pharmaceuticals Announces $61 Million Private Placement (10/29/10)
  Posted 10/29/10 at 5:51pm via aveopharma.com
• 
  AVEO Pharmaceuticals received $25M in Venture Round funding. (5/28/10)
  Posted 7/8/10 at 8:17pm via alacrastore.com
• 
  AVEO Pharmaceuticals — Aveo Delays IPO (3/11/10)
  Posted 3/30/10 at 6:56pm via fiercebiotech.com
• 
  Went public with stock symbol AVEO. (3/11/10)
  Posted 7/2/10 at 12:32pm
• 
  AVEO Pharmaceuticals — AVEO files for $86.3M IPO (12/17/09)
  Posted 12/17/09 at 3:19pm via masshightech.com
• 
  AVEO Pharmaceuticals received $20M in Venture Round funding. (7/21/09)
  Posted 7/28/09 at 1:16pm via fiercebiotech.com
• 
  AVEO Pharmaceuticals added Donna M. Radzik as VP Technical operations.
  Posted 9/15/10 at 8:17pm
• 
  AVEO Pharmaceuticals added Michael P. Bailey as Chief Commercial Officer.
  Posted 9/15/10 at 8:17pm
• 
  AVEO Pharmaceuticals added Tuan Ha-Ngoc as President & CEO.
  Posted 9/15/10 at 8:17pm
• 
  AVEO Pharmaceuticals added Henri A. Termeer as Board of Directors.
  Posted 4/12/11 at 8:36pm

Videos

Screenshots

edit

Stock Price

Sources

1. Aveo grabs $20M in expanded OSI collaboration (fiercebiotech.com) [edit]
2. Hercules Technology Growth Capital provides $25 million commitment to Aveo Pharmaceuticals (alacrastore.com) [edit]
Aveo Pharma files for up to $86.3M IPO (masshightech.com) [edit]
Aveo Pharma delays IPO, at least briefly (fiercebiotech.com) [edit]
AVEO Pharmaceuticals Announces $61 Million Private Placement (investor.aveopharma.com) [edit]
Aveo to offer $61M stock offering (masshightech.com) [edit]
AVEO releases data on cancer drugs (masshightech.com) [edit]
Aveo nabs $1.4B deal with Astellas for Ph3 cancer drug (fiercebiotech.com) [edit]
AVEO, Astellas form potential $1.4B drug development deal (masshightech.com) [edit]
Aveo deal with Centocor could be sweetened by up to $540M (masshightech.com) [edit]
Aveo Pharmaceuticals files for $100M stock offering (masshightech.com) [edit]